Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging false advertising and deceptive marketing for Zepbound and Mounjaro treatments.
Novo Nordisk says Eli Lilly is advertising their weight loss drugs in a misleading way, so they're taking them to court. When big companies fight over who's telling the truth, it can make people worry about whether to trust either company.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.